FBB
TMO icon

Fulton Breakefield Broenniman’s Thermo Fisher Scientific TMO Stock Holding History

Fulton Breakefield Broenniman’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$300K Buy
610
+9
+1% +$4.88K 0.02% 151
2025
Q4 		$348K Sell
601
-83
-12% -$46.9K 0.02% 147
2025
Q3 		$332K Buy
684
+62
+10% +$28.9K 0.02% 150
2025
Q2 		$252K Buy
622
+148
+31% +$61.9K 0.02% 170
2025
Q1 		$236K Sell
474
-11
-2% -$5.96K 0.02% 163
2024
Q4 		$252K Hold
485
– – 0.02% 161
2024
Q3 		$300K Sell
485
-183
-27% -$108K 0.02% 145
2024
Q2 		$369K Sell
668
-8
-1% -$4.58K 0.03% 130
2024
Q1 		$393K Hold
676
– – 0.03% 126
2023
Q4 		$359K Sell
676
-148
-18% -$71.6K 0.03% 129
2023
Q3 		$417K Hold
824
– – 0.04% 117
2023
Q2 		$430K Sell
824
-3
-0.4% -$1.62K 0.04% 121
2023
Q1 		$476K Buy
827
+4
+0.5% +$2.25K 0.04% 114
2022
Q4 		$453K Hold
823
– – 0.04% 117
2022
Q3 		$417K Buy
823
+1
+0.1% +$560 0.04% 111
2022
Q2 		$447K Buy
822
+11
+1% +$6.05K 0.04% 116
2022
Q1 		$479K Sell
811
-10
-1% -$5.74K 0.04% 104
2021
Q4 		$547K Buy
+821
New +$513K 0.04% 116

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fulton Breakefield Broenniman's TMO Position: Q1 2026 in Review

Fulton Breakefield Broenniman increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, buying an estimated $4.88K and bringing the position to 610 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #151.

Fulton Breakefield Broenniman first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $547K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fulton Breakefield Broenniman held 610 shares of Thermo Fisher Scientific worth $300K as of Q1 2026.
  • Fulton Breakefield Broenniman bought 9 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.88K.
  • Thermo Fisher Scientific made up 0.02% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #151 holding.
  • Fulton Breakefield Broenniman first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
  • Fulton Breakefield Broenniman's Thermo Fisher Scientific position peaked at $547K in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.